                         SEQUENCE LISTING

<110>  BEDU-ADDO, Frank
       JACOBSON, Eric
       JOHNSON, Kenya
 
<120>  IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE

<130>  50165-226723

<140>  PCT/US2013/061132
<141>  2013-09-23

<150>  61/703814
<151>  2012-09-21

<160>  11    

<170>  PatentIn version 3.3

<210>  1
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  1

Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  2
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  2

Gly Gln Ala Glu Pro Asp Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   10                  15  


<210>  3
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  3

Lys Ser Ser Gly Gln Ala Glu Pro Asp Arg Ala His Tyr Asn Ile Val 
1               5                   10                  15      


Thr Phe 
        


<210>  4
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  4

Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10  


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  5

Lys Ser Ser Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10              


<210>  6
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  6

Lys Ser Ser Met His Gly Asp Thr Pro Thr Leu His Glu Tyr Met Leu 
1               5                   10                  15      


Asp Leu Gln Pro Glu Thr Thr 
            20              


<210>  7
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  7

Lys Ser Ser Leu Leu Met Gly Thr Leu Gly Ile Val Cys Pro Ile Cys 
1               5                   10                  15      


Ser Gln Lys Pro 
            20  


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  8

Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  9

Ser Tyr Val Asp Phe Phe Val Trp Leu 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  10

Lys Tyr Ile Cys Asn Ser Ser Cys Met 
1               5                   


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Elongated peptide

<400>  11

Lys Ser Ser Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10          


